Corporal Anna Cross cured of Ebola says 'Eating strawberries saved my life'

Corporal Anna Cross, 25, from Cambridge, who was the first person in the world to be treated with the experimental drug MIL 77, credits the humble strawberry with helping save her life.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Discussions with the FDA are ongoing to define the required data set for filing Janssen’s Ebola vaccine regimen under the FDA’s Animal Rule licensure pathway. About Janssen’s Ebola Vaccine Regimen The Janssen investigational preventive Ebola vaccine regimen (Ad26.ZEBOV, MVA-BN-Filo) utilizes a viral vector strategy in which viruses – in this case adenovirus serotype 26 (Ad26) and Modified Vaccinia Virus Ankara (MVA) – are genetically modified so that they cannot replicate in human cells. In addition, these vectors are modified to safely carry the genetic code of an Ebola virus protein in order...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
A panel of the European health regulator on Friday recommended approving Johnson&Johnson's two-dose experimental vaccine for Ebola in the European Union.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
CBS News' Debora Patta gets a harrowing look as doctors battle the clock and a killer disease to save lives — a fight they simply can't always win.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
From 20 to 26 May 2020, no new cases of Ebola virus disease (EVD) have been reported from the Democratic Republic of the Congo (Figure 1).
Source: WHO Disease Outbreaks - Category: Infectious Diseases Tags: news Source Type: news
This article is protected by copyright. All rights reserved. PMID: 32463974 [PubMed - as supplied by publisher]
Source: Biotechnology Journal - Category: Biotechnology Authors: Tags: Biotechnol J Source Type: research
The most commonly reported symptom of post-Ebola virus disease syndrome in survivors is arthralgia, yet involvement of the joints in acute or convalescent Ebola virus infection has not been well-characterized in human patients or animal models. By immunohistochemistry, we found that the lining synovial intima of the stifle (knee) is a target for acute infection by Ebola virus/Kikwit, Ebola virus/Makona-C05, and Marburg virus/Angola in the rhesus macaque model. Further, we demonstrate by histology, immunohistochemistry, RNAscope in situ hybridization, and transmission electron microscopy that synoviocytes of the stifle, sho...
Source: American Journal of Pathology - Category: Pathology Authors: Tags: Regular Article Source Type: research
The COVID-19 pandemic has had significant global consequences, with healthcare systems stretched to their limits, a growing death toll, and economic devastation as economies came grinding to a halt. The pandemic and its aftereffects will be with u...
Source: Medgadget - Category: Medical Devices Authors: Tags: Exclusive Medicine Public Health Source Type: blogs
Early trials of remdesivir have suggested that it can speed up people's time to recovery by four days, British officials said, and doctors will now be able to give it to any hospital patients who might benefit.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Drug pioneered for Ebola to be used in UK under emergency medicines provisionCoronavirus – latest updatesSee all our coronavirus coverageA drug that reduces recovery time from Covid-19 will be made available to a number of NHS patients in “probably the biggest step forward in the treatment of coronavirus” since the pandemic began, the UK health secretary has said.Matt Hancock on Tuesday welcomed the authorisation of the experimental antiviral drug remdesivir, which has been shown to reduce recovery time for patients in hospital with Covid-19 from 15 days to 11 days.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak UK news Drugs NHS UCL (University College London) London School of Hygiene & Tropical Medicine Infectious diseases Medical research Microbiology Science US news China World news Source Type: news
CORONAVIRUS has been plaguing the world since it was first found in Wuhan, China, in December 2019. Could the bole drug Remdesivir be used to treat COVID-19?
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
More News: Ebola | Health | Strawberries